company

Diabetes Developments - A blog on latest developments in diabetes by David Mendosa

Advanced
Categories
- Basics (14)
- Book Reviews (4)
- Complications (70)
- Diabetes Developments (20)
- Exercise (56)
- Food (212)
- Medication (105)
- People (9)
- Psychosocial (86)
- Testing (110)
Recent Posts
Most Popular Posts
Tags
blood glucose byetta david mendosa diabetes Diabetes Diet Diabetes Drugs Diabetes Management Diabetes Research Diabetes Risks diabetes treatment diet drugs eating Exercise facts Fitness Food Highs And Lows information Inspirational Living With Diabetes Medication nutrition research study Testing Type 1 type 2 walking weight-loss
Recent Comments
- David Mendosa on Kimchi Makes People with Diabetes Smile
- Kathy on Kimchi Makes People with Diabetes Smile
- ChandraShekar on Walking Equals Running for Heart and Diabetes Health
- David Mendosa on Arginine: A Marvel or Quackery?
- Teri Grottke on Arginine: A Marvel or Quackery?
Archives

Advertisment

Investing in Diabetes

October 2nd, 2006 · 2 Comments

Right now I’m disinvesting. I sold my AMLN shares today.

AMLN is the NASDAQ stock symbol for Amylin Pharmaceuticals Inc. in San Diego, which developed Byetta. [Read more →]

Tags: company, investing, money
Posted in: Psychosocial